14-15 MATSUMOTO Nihonbashiodenma cho Building, Chuo-ku, Tokyo 〒 103-0011
IPO Global Research aggregates information on public companies and private companies, such as Softmax IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Our research is available by annual or monthly subscription or by one-week snapshots and single-company reports. Be informed.
Softmax is a porvider of medical solutions in relation to the development of patient medical care, such as medical records, electronic accounting.This description is adapted from =$displayshorter;?> prospectus. This description is not intended to be a recommendation to buy stock from this company. We do not claim that all of the statements above were researched and found to be true. We present them as a general description based on what the company has said about itself at the time that they submitted their prospectus for an IPO offering. To see the company's full description, view their prospectus..
© 2017 IPO Global Research. All Rights Reserved